Exact Sciences Corp

자세한 내용은 Exact Sciences Corp 회사

Exact Sciences Corporation is a provider of cancer screening and diagnostic tests. The Company provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. It is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

회사 정보

종목 코드 EXAS

회사 이름Exact Sciences Corp

상장일Jan 30, 2001

설립일1995

CEOMr. Kevin T. Conroy

직원 수6900

유형Ordinary Share

회계 연도 종료Jan 30

주소5505 Endeavor Lane

도시MADISON

증권 거래소NASDAQ Capital Market Consolidated

국가United States of America

우편 번호53719

전화16082845700

웹사이트https://www.exactsciences.com/

종목 코드 EXAS

상장일Jan 30, 2001

설립일1995

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

Ms. Kimberly J. (Kim) Popovits

Independent Director

16.38K

+156.47%

Mr. Aaron Bloomer

Chief Financial Officer, Executive Vice President

13.84K

--

Mr. Michael J. (Mike) Barber, M.D.

Independent Director

13.14K

+121.18%

Mr. James E. Doyle

Lead Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Kevin T. Conroy

Chairman of the Board, President, Chief Executive Officer

1.14M

-20.54%

Ms. Katherine S. (Kay) Zanotti

Independent Director

72.76K

+3.10%

Mr. Daniel J. (Dan) Levangie

Independent Director

34.31K

+18.67%

Ms. Shacey Petrovic

Independent Director

28.90K

+22.97%

Mr. Brian Baranick

Executive Vice President, General Manager - Precision Oncology

23.26K

+0.94%

Ms. Leslie L. Trigg

Independent Director

17.17K

+80.75%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

사업별USD

이름

수익

비율

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

지역별USD

이름

수익

비율

United States (Country)

655.20M

92.70%

Outside of united states

51.59M

7.30%

사업별

지역별

사업별USD

이름

수익

비율

Commercial

332.50M

47.04%

Medicare Parts B & C

247.89M

35.07%

Other

74.81M

10.58%

International

51.59M

7.30%

주식 보유 통계

마지막 업데이트: Wed, Jul 23

주주

주주 유형

주주

비율

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

주주

비율

Fidelity Management & Research Company LLC

12.80%

Capital World Investors

9.45%

The Vanguard Group, Inc.

9.31%

Wellington Management Company, LLP

6.63%

BlackRock Institutional Trust Company, N.A.

4.07%

Other

57.74%

주주 유형

주주

비율

Investment Advisor

60.66%

Investment Advisor/Hedge Fund

28.14%

Hedge Fund

4.34%

Research Firm

2.48%

Bank and Trust

1.36%

Pension Fund

1.14%

Individual Investor

0.92%

Sovereign Wealth Fund

0.54%

Private Equity

0.36%

Other

0.05%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1397

201.71M

106.93%

+2.11M

2025Q1

1424

199.78M

106.03%

-445.52K

2024Q4

1411

200.72M

108.09%

-225.66K

2024Q3

1375

190.82M

103.28%

-5.17M

2024Q2

1358

185.25M

100.40%

+6.59M

2024Q1

1347

168.41M

92.78%

-6.10M

2023Q4

1356

165.31M

91.41%

-11.01M

2023Q3

1337

167.70M

92.83%

-6.22M

2023Q2

1354

166.38M

92.24%

-10.65M

2023Q1

1343

167.01M

92.90%

-8.56M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Fidelity Management & Research Company LLC

24.14M

12.8%

+5.29M

+28.03%

Mar 31, 2025

Capital World Investors

17.84M

9.45%

+297.66K

+1.70%

Mar 31, 2025

The Vanguard Group, Inc.

17.56M

9.31%

+616.59K

+3.64%

Mar 31, 2025

Wellington Management Company, LLP

12.50M

6.63%

+442.78K

+3.67%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

7.68M

4.07%

+12.62K

+0.16%

Mar 31, 2025

State Street Global Advisors (US)

6.61M

3.51%

+381.12K

+6.11%

Mar 31, 2025

T. Rowe Price Associates, Inc.

6.25M

3.32%

+631.23K

+11.22%

Mar 31, 2025

Fidelity Institutional Asset Management

3.59M

1.9%

+1.68M

+88.60%

Mar 31, 2025

Mackenzie Investments

3.28M

1.74%

+362.31K

+12.41%

Mar 31, 2025

Geode Capital Management, L.L.C.

3.27M

1.73%

+143.64K

+4.60%

Mar 31, 2025

46.950USD

Exact Sciences Corp

46.950

개요

회사

금융